US20050008762A1 - Method of marking solid or liquid substances with nucleic acid for anti-counterfeiting and authentication - Google Patents

Method of marking solid or liquid substances with nucleic acid for anti-counterfeiting and authentication Download PDF

Info

Publication number
US20050008762A1
US20050008762A1 US10/748,412 US74841203A US2005008762A1 US 20050008762 A1 US20050008762 A1 US 20050008762A1 US 74841203 A US74841203 A US 74841203A US 2005008762 A1 US2005008762 A1 US 2005008762A1
Authority
US
United States
Prior art keywords
nucleic acid
mixture
water
marking
solvent
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
US10/748,412
Other versions
US7115301B2 (en
Inventor
Jue-Jei Sheu
Lin-Lin Chen
Emma Chen
Benjamin Liang
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
APDN BVI Inc
Original Assignee
BIOWELL TECHNOLOGY Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US09/832,048 external-priority patent/US20020187263A1/en
Assigned to BIOWELL TECHNOLOGY INC. reassignment BIOWELL TECHNOLOGY INC. ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: CHEN, EMMA, CHEN, LIN-LIN, LIANG, BENJAMIN, SHEU, JUE-JEI
Priority to US10/748,412 priority Critical patent/US7115301B2/en
Application filed by BIOWELL TECHNOLOGY Inc filed Critical BIOWELL TECHNOLOGY Inc
Publication of US20050008762A1 publication Critical patent/US20050008762A1/en
Assigned to RIXFLEX HOLDINGS LIMITED reassignment RIXFLEX HOLDINGS LIMITED ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: BIOWELL TECHNOLOGY INC.
Publication of US7115301B2 publication Critical patent/US7115301B2/en
Application granted granted Critical
Assigned to APDN (B.V.I) INC. reassignment APDN (B.V.I) INC. MERGER (SEE DOCUMENT FOR DETAILS). Assignors: APDN (B.V.I.) INC., RIXFLEX HOLDINGS LIMITED
Assigned to ETICO CAPITAL, LLC reassignment ETICO CAPITAL, LLC PATENT SECURITY AGREEMENT Assignors: APDN (B.V.I.) INC.
Assigned to APDN (B.V.I.) INC. reassignment APDN (B.V.I.) INC. RELEASE BY SECURED PARTY (SEE DOCUMENT FOR DETAILS). Assignors: ETICO CAPITAL, LLC
Assigned to DELAWARE TRUST COMPANY reassignment DELAWARE TRUST COMPANY SECURITY INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: APDN (B.V.I.) INC.
Assigned to DELAWARE TRUST COMPANY reassignment DELAWARE TRUST COMPANY SECURITY INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: APDN (B.V.I.) INC.
Assigned to APDN (B.V.I.) INC. reassignment APDN (B.V.I.) INC. SECURITY INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: DELAWARE TRUST COMPANY
Adjusted expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Images

Classifications

    • GPHYSICS
    • G09EDUCATION; CRYPTOGRAPHY; DISPLAY; ADVERTISING; SEALS
    • G09FDISPLAYING; ADVERTISING; SIGNS; LABELS OR NAME-PLATES; SEALS
    • G09F3/00Labels, tag tickets, or similar identification or indication means; Seals; Postage or like stamps

Definitions

  • the present invention relates to a method of marking solid or liquid substances with nucleic acid for anti-counterfeiting and authentication, specifically to a method for marking solid or liquid substances with nucleic acid dissolved in a water insoluble medium through the addition of an intermediate solution.
  • biotechnology With the development of biotechnology, the application of biotechnology is not limited to the research work in laboratory anymore. In clinical field, the process of prevention, identification, and even the treatment of diseases are also combined with the advanced molecular biology techniques for optimal performance. Utilization of biotechnological methods to improve crops and the livestock are a routine practice. Furthermore, in combination with digital system, individual biological features are converted into digital signals and utilized, such as switching on household appliances by the one's voice or the utilization of individual fingerprints or irises for security identification. The application of biotechnology to daily life matters is an inevitable trend for the future.
  • RNA and DNA contains essential hereditary information.
  • RNA and DNA are long polymers consisted of only 4 nucleotides, adenine (A), guanine (G), cytosine (C) and thymine (T) for DNA (or uracil (U) for RNA).
  • the nucleotide structure can be broken down into 2 parts, the sugar-phosphate backbone and the base. All nucleotides share the sugar-phosphate backbone.
  • the 3′-hydroxyl group on the ribose unit reacts with the 5′-phosphate group on it's neighbor to form a chain structure.
  • A, T, G and C are capable of specific-pairing to form a double strand.
  • Adenine forms two hydrogen bonds with thymine in DNA (uracil in RNA) and cytosine forms three hydrogen bonds with guanine. That is, T will bond to A only and G to C only.
  • Nucleic acids are susceptible to modifiers and degraders such as UV radiation and enzymes, however, with proper protection nucleic acids can be preserved over a long period of time. Fossil evidence shows that DNA is resistant to degradation over millions of years and is being used to learn more about ancient people and animals. Protected DNA can be stable and can be used as an identification marker. In addition, the ability to perform downstream reactions on nucleic acid molecules, such as PCR, is not affected by subjecting nucleic acid to extreme conditions of heat, which is the great advantage of nucleic acid for labeling.
  • Taggants take advantage of physical or chemical properties of materials. For example, magnetic strips on checkbooks, laser holographs on credit cards, fluorescent ink on stocks, and heat-sensitive inks. However, those labels can be easily mimicked and destroyed.
  • nucleic acid is used for anti-counterfeiting now. It is well known to persons skilled in the related art that nucleic acid, a highly water-soluble molecule, easily dissolves in water-soluble solution, such as TE buffer. However, it seems impracticable to dissolve nucleic acid with water-insoluble solvents or medium.
  • DNA is dissolved in distilled water and spread on the target. However, DNA taggants dissolved in water are easily removed after drying and the labeling is not lasting.
  • detergents such as Span®80 are needed for mixing the DNA taggants with the non-polar liquids or oils to be labeled in EP 0 477 220 B1.
  • this type of DNA taggants cannot adhere on the objects for a long period of time and may lose the anti-counterfeiting function easily.
  • the present invention is directed to a method of marking solid or liquid substance with nucleic acid for anti-counterfeiting and authentication that substantially obviates one or more of the problems due to limitations and disadvantages of the related art.
  • a primary object of the present invention is to provide a method of marking solid or liquid substance with nucleic acid for anti-counterfeiting and authentication, in which nucleic acids are dissolved in a water-insoluble medium and forms a homogenous solution.
  • Another object of the present invention is to provide a method of marking solid or liquid substance with nucleic acid for anti-counterfeiting and authentication in which the nucleic acid taggants are specific and not easily mimicked.
  • Still object of the present invention is to provide a method of marking solid or liquid substance with nucleic acid for anti-counterfeiting and authentication, in which the nucleic acid taggants are not easily damaged and erased in the water-insoluble medium.
  • a method of marking solid substance with nucleic acid for anti-counterfeiting and authentication is provided.
  • a water-insoluble medium is dissolved in a first solvent to form the first mixture, the medium/solvent mixture.
  • a nucleic acid solution is mixed with an intermediate solution to form a homogenous second mixture.
  • the second mixture is mixed with the first mixture and forms a homogenous third mixture.
  • the intermediate solution increases the miscibility between the nucleic acid solution and the water-insoluble medium/solvent solution.
  • the medium is an inert medium and is not deteriorative to the nucleic acid and substances.
  • a nucleic acid is dissolved in an aqueous solution to form a first mixture.
  • the first mixture is mixed with an intermediate solution to form a second mixture.
  • the second mixture is mixed with a water insoluble solvent to form a homogenous third mixture.
  • the intermediate solution increases the miscibility between the nucleic acid solution and the water insoluble solvent.
  • the solubility of a solute in a given solvent is known as a function of the polarity of the solvent.
  • Solvents may be considered polar, semi-polar or non-polar.
  • Polar solvents will dissolve ionic and other polar solutes (i.e. those with an asymmetric charge distribution [like dissolves like]), whereas, non-polar solvents will dissolve non-polar molecules.
  • Semi-polar solvents for example, alcohols and acetones, may induce a certain degree of polarity in non-polar molecules and may thus act to improve the miscibility of polar and non-polar liquids.
  • the dielectric constant (e) of a compound is an index of its polarity.
  • nucleic acid is polar molecules while the water-insoluble medium dissolved in the first solvent is a non-polar one.
  • An intermediate solution of semi-polarity is used to increase the miscibility between the nucleic acid and the medium/solvent mixture.
  • the nucleic acid used is selected from a group consisting of natural and synthetic nucleic acid.
  • naturally nucleic acid as used herein means nucleic acid prepared from all prokaryotes, viruses, fungi, eukaryotes, such as animals, plants, and other organisms.
  • synthetic nucleic acid includes synthetic vectors and synthetic nucleic acid fragments.
  • Nucleic acid is dissolved in a water-soluble solution to form the nucleic acid solution.
  • the water-soluble solution may be water, TE buffer or other buffers.
  • the medium is an inert medium and is not deteriorative to nucleic acid and substance to be labeled.
  • the water-insoluble medium comprises a polymeric substance, for example, polypropylene (PP), polymethyl methacrylate (PMMA), polycarbonate (PC) and polystyrene (PS).
  • PP polypropylene
  • PMMA polymethyl methacrylate
  • PC polycarbonate
  • PS polystyrene
  • the water-insoluble medium used is polystyrene (PS) and polystyrene (PC).
  • the first solvent is selected from a group consisting of chloroform, dichloromethane and benzole solvent, such as xylene or toluene.
  • benzole solvent such as xylene or toluene.
  • other organic solvent known in the related art may also be used.
  • the intermediate solution is used to increase the miscibility between the nucleic acid and the medium/solvent mixture.
  • the intermediate solution used herein preferably comprises a semi-polar solvent of which the dielectric constant is preferably between 20 and 50.
  • the intermediate solution is selected from a group consisting of methanol, ethanol, acetone, glycerol and their mixture.
  • the above-mentioned solid substances or articles include antiques, paintings, jewelry, identification cards, credit cards, magnetic strip cards, sports collectibles, souvenirs and other solid collectibles.
  • the foregoing liquid includes inks, paints, dyes, dyestuffs, color wash, pigments, seals, glues, cosmetics and others. After labeling with nucleic acid, the objects have anti-counterfeiting function.
  • the water-insoluble medium containing known nucleic acid taggants is spread on the target solid substances or articles. After drying, the nucleic acid taggants protected by the water-insoluble medium adhere on the surface of the object.
  • the target liquid is mixed with the water-insoluble media containing known nucleic acid taggants. As a result, the target liquid is labeled with nucleic acid.
  • products with nucleic acid labeled are manufactured by means of materials of water-insoluble medium containing nucleic acid taggants.
  • Both solid and liquid are labeled in the present invention.
  • a small portion of the labeled substances is dissolved with an organic solvent and then mixed with a buffer of high nucleic acid solubility.
  • the nucleic acid taggants dissolved in the buffer are separated and collected from the solvent by centrifugation. Finally, the collected nucleic acid taggants are amplified by Polymerase Chain Reaction (PCR) and examined by gel electrophoresis.
  • PCR Polymerase Chain Reaction
  • the sequence of the nucleic acid taggant is specific, the original nucleic acid will be amplified only with the primers of specific sequences. In addition, the concentration of the nucleic acid in the medium is so low that the sequence of the nucleic acid taggant is hard to be decoded. The purpose of anti-counterfeiting is then achieved.
  • FIG. 1 shows 800 base pair (bp) DNA taggants which are recovered from a small portion of a plastic film, amplified by PCR and stained with ethidium bromide (EtBr) after gel electrophoresis.
  • FIG. 2 shows 600 bp human WBC DNA taggants recovered from a small portion of a plastic film, amplified by PCR and stained with ethidium bromide (EtBr) after gel electrophoresis.
  • EtBr ethidium bromide
  • FIG. 3 shows 500 bp E. coli plasmid DNA taggants recovered from paraffin oil, amplified by PCR and stained with ethidium bromide (EtBr) after gel electrophoresis.
  • DNA solution containing the intermediate solution is mixed homogeneously with the PS/chloroform solution through vigorous vortex.
  • water-soluble DNA solution and water-insoluble medium of PS/chloroform solution are mixed completely to form a homogenous medium containing desired DNA.
  • Synthesized DNA of 800 bp is dissolved in 95% ethanol and acetone in equal amount and mixed with polycarbonate/chloroform solution as mentioned above.
  • a plastic film is spread with the homogenous medium containing desired DNA and air-dried. After drying, the plastic film is placed in the dark, or at 4° C. Alternatively, the plastic film is exposed to sunlight for one day before recovery. For recovery, a small piece of the plastic film is dissolved with chloroform. TE buffer is added and mixed well with the dissolved plastic film in chloroform and then centrifuged. The supernatants are collected and served as the templates for PCR. PCR products are then analyzed by electrophoresis and stained with EtBr. As indicated in FIG.
  • samples labeled with DNA taggants show a clear band of 800 bp on the gel.
  • L 1 is the standard 100 bp DNA ladder.
  • L 2 is PCR products amplified from the sample retrieved from the dark.
  • L 3 , L 4 , and L 5 are PCR products amplified from samples exposed under sunlight.
  • L 6 , L 7 , and L 8 are PCR products amplified from samples of 4° C. treatment. Results show that DNA taggants of 800 bp can be recovered from the plastic films with three different treatments and verified through electrophoresis after amplification of PCR.
  • the extracted Human WBC DNA is dissolved in 95% ethanol and equal amount of acetone and then mixed with polycarbonate/chloroform solution as mentioned above.
  • the plastic film is spread with the homogenous medium containing desired DNA and air-dried. After drying, the plastic film is placed in the dark, or at 4° C. Alternatively, the plastic film is exposed to sunlight for one day before recovery. For recovery, a small piece of the plastic film is dissolved with chloroform. TE buffer is added and mixed well with the dissolved plastic film in chloroform and then centrifuged. The supernatants are collected and served as the templates for PCR. PCR products are then analyzed by electrophoresis and stained with EtBr. As indicated in FIG.
  • L 1 is the standard 100 bp DNA ladder.
  • L 2 and L 3 are PCR products amplified from the template of 1 ⁇ l of the supernatant.
  • L 4 and L 5 are PCR products amplified from the template of 2 ⁇ l of the supernatant.
  • L 6 is the PCR product amplified without DNA template (the negative control).
  • L 7 is the PCR product amplified with human WBC DNA (positive control). Results show that human WBC DNA can be recovered from the plastic films with three different treatments and verified through electrophoresis after amplification of PCR.
  • L 1 1 ⁇ l of E. coli plasmid DNA (100 pg/ ⁇ l) is dissolved in 5 ⁇ l water and then mixed with paraffin oil directly.
  • L 1 is a comparison treatment.
  • L 2 1 ⁇ l of E. coli plasmid DNA (100 pg/ ⁇ l) is added in 50 ⁇ l polycarbonate first and then with paraffin oil.
  • L 3 is the negative control, which contains only paraffin oil and polycarbonate/chloroform solution.
  • LA is the positive control, which contains only E. coli plasmid DNA.
  • L 1 ⁇ L 4 are centrifuged at 6000 g for 1 minute.

Abstract

The present invention relates to a method of marking solid or liquid substances with nucleic acid for anti-counterfeiting and authentication, specifically to a method for marking solid or liquid substances with nucleic acid dissolved in a water insoluble medium. Through the addition of an intermediate solution, the miscibility between the nucleic acid solution and the medium is increased and forms a homogenous solution. For marking solid substances or articles, the water-insoluble medium containing known nucleic acid taggants is spread on the target solid substances or articles. After drying, nucleic acids protected by the water-insoluble medium adhere on surface of the object. For marking liquid, the target liquid is mixed with the water-insoluble media containing known nucleic acid taggants. As a result, the target liquid is labeled with nucleic acid.

Description

    CROSS-REFERENCE TO RELATED APPLICATION
  • This application is a continuation-in-part of U.S. Ser. No. 09/832,048 filed on Apr. 9, 2001, disclosure of which is incorporated herein by reference.
  • FIELD OF THE INVENTION
  • The present invention relates to a method of marking solid or liquid substances with nucleic acid for anti-counterfeiting and authentication, specifically to a method for marking solid or liquid substances with nucleic acid dissolved in a water insoluble medium through the addition of an intermediate solution.
  • DESSCRIPTION OF THE RELATED ART
  • With the development of biotechnology, the application of biotechnology is not limited to the research work in laboratory anymore. In clinical field, the process of prevention, identification, and even the treatment of diseases are also combined with the advanced molecular biology techniques for optimal performance. Utilization of biotechnological methods to improve crops and the livestock are a routine practice. Furthermore, in combination with digital system, individual biological features are converted into digital signals and utilized, such as switching on household appliances by the one's voice or the utilization of individual fingerprints or irises for security identification. The application of biotechnology to daily life matters is an inevitable trend for the future.
  • Nucleic acids, Ribonucleic acid (RNA) and Deoxyribonucleic acid (DNA) contains essential hereditary information. RNA and DNA are long polymers consisted of only 4 nucleotides, adenine (A), guanine (G), cytosine (C) and thymine (T) for DNA (or uracil (U) for RNA). The nucleotide structure can be broken down into 2 parts, the sugar-phosphate backbone and the base. All nucleotides share the sugar-phosphate backbone. The 3′-hydroxyl group on the ribose unit, reacts with the 5′-phosphate group on it's neighbor to form a chain structure. A, T, G and C are capable of specific-pairing to form a double strand. Adenine forms two hydrogen bonds with thymine in DNA (uracil in RNA) and cytosine forms three hydrogen bonds with guanine. That is, T will bond to A only and G to C only.
  • Nucleic acids are susceptible to modifiers and degraders such as UV radiation and enzymes, however, with proper protection nucleic acids can be preserved over a long period of time. Fossil evidence shows that DNA is resistant to degradation over millions of years and is being used to learn more about ancient people and animals. Protected DNA can be stable and can be used as an identification marker. In addition, the ability to perform downstream reactions on nucleic acid molecules, such as PCR, is not affected by subjecting nucleic acid to extreme conditions of heat, which is the great advantage of nucleic acid for labeling.
  • Two identification methods are commonly used nowadays. One is the utilization of the unique features of the merchandise, another way is to label or mark objects with specific taggants. Traditional taggants take advantage of physical or chemical properties of materials. For example, magnetic strips on checkbooks, laser holographs on credit cards, fluorescent ink on stocks, and heat-sensitive inks. However, those labels can be easily mimicked and destroyed.
  • Owing to the advantage of specific binding, nucleic acid is used for anti-counterfeiting now. It is well known to persons skilled in the related art that nucleic acid, a highly water-soluble molecule, easily dissolves in water-soluble solution, such as TE buffer. However, it seems impracticable to dissolve nucleic acid with water-insoluble solvents or medium. In EP 0 477 220 B1, DNA is dissolved in distilled water and spread on the target. However, DNA taggants dissolved in water are easily removed after drying and the labeling is not lasting. In addition, detergents such as Span®80 are needed for mixing the DNA taggants with the non-polar liquids or oils to be labeled in EP 0 477 220 B1. However, this type of DNA taggants cannot adhere on the objects for a long period of time and may lose the anti-counterfeiting function easily.
  • SUMMARY OF THE INVENTION
  • Accordingly, the present invention is directed to a method of marking solid or liquid substance with nucleic acid for anti-counterfeiting and authentication that substantially obviates one or more of the problems due to limitations and disadvantages of the related art.
  • A primary object of the present invention is to provide a method of marking solid or liquid substance with nucleic acid for anti-counterfeiting and authentication, in which nucleic acids are dissolved in a water-insoluble medium and forms a homogenous solution.
  • Another object of the present invention is to provide a method of marking solid or liquid substance with nucleic acid for anti-counterfeiting and authentication in which the nucleic acid taggants are specific and not easily mimicked.
  • Still object of the present invention is to provide a method of marking solid or liquid substance with nucleic acid for anti-counterfeiting and authentication, in which the nucleic acid taggants are not easily damaged and erased in the water-insoluble medium.
  • In order to achieve the foregoing objects, a method of marking solid substance with nucleic acid for anti-counterfeiting and authentication is provided. A water-insoluble medium is dissolved in a first solvent to form the first mixture, the medium/solvent mixture. A nucleic acid solution is mixed with an intermediate solution to form a homogenous second mixture. The second mixture is mixed with the first mixture and forms a homogenous third mixture. The intermediate solution increases the miscibility between the nucleic acid solution and the water-insoluble medium/solvent solution. The medium is an inert medium and is not deteriorative to the nucleic acid and substances.
  • In the case of making a water insoluble liquid with nucleic acid for anti-counterfeiting and authentication, a similar method to the above mentioned but with little difference. A nucleic acid is dissolved in an aqueous solution to form a first mixture. The first mixture is mixed with an intermediate solution to form a second mixture. The second mixture is mixed with a water insoluble solvent to form a homogenous third mixture. The intermediate solution increases the miscibility between the nucleic acid solution and the water insoluble solvent.
  • The solubility of a solute in a given solvent is known as a function of the polarity of the solvent. Solvents may be considered polar, semi-polar or non-polar. Polar solvents will dissolve ionic and other polar solutes (i.e. those with an asymmetric charge distribution [like dissolves like]), whereas, non-polar solvents will dissolve non-polar molecules. Semi-polar solvents, for example, alcohols and acetones, may induce a certain degree of polarity in non-polar molecules and may thus act to improve the miscibility of polar and non-polar liquids. The dielectric constant (e) of a compound is an index of its polarity. Solvents are usually classified according to their dielectric constants as polar (e>50), semi-polar (e=20-50), or non-polar (e=1-20). In the present invention, nucleic acid is polar molecules while the water-insoluble medium dissolved in the first solvent is a non-polar one. An intermediate solution of semi-polarity is used to increase the miscibility between the nucleic acid and the medium/solvent mixture.
  • The term “nucleic acid” used in the present invention comprises both deoxyribonucleic acid (DNA) and ribonucleic acid (RNA). The nucleic acid used is selected from a group consisting of natural and synthetic nucleic acid. The term “natural nucleic acid” as used herein means nucleic acid prepared from all prokaryotes, viruses, fungi, eukaryotes, such as animals, plants, and other organisms. The term “synthetic nucleic acid” includes synthetic vectors and synthetic nucleic acid fragments.
  • Nucleic acid is dissolved in a water-soluble solution to form the nucleic acid solution. The water-soluble solution may be water, TE buffer or other buffers.
  • The medium is an inert medium and is not deteriorative to nucleic acid and substance to be labeled. The water-insoluble medium comprises a polymeric substance, for example, polypropylene (PP), polymethyl methacrylate (PMMA), polycarbonate (PC) and polystyrene (PS). In the following preferred embodiments, the water-insoluble medium used is polystyrene (PS) and polystyrene (PC).
  • The first solvent used herein is to dissolve the water-insoluble medium comprises an organic solvent. As used herein, the first solvent is selected from a group consisting of chloroform, dichloromethane and benzole solvent, such as xylene or toluene. However, other organic solvent known in the related art may also be used.
  • The intermediate solution is used to increase the miscibility between the nucleic acid and the medium/solvent mixture. The intermediate solution used herein preferably comprises a semi-polar solvent of which the dielectric constant is preferably between 20 and 50. The intermediate solution is selected from a group consisting of methanol, ethanol, acetone, glycerol and their mixture.
  • The above-mentioned solid substances or articles include antiques, paintings, jewelry, identification cards, credit cards, magnetic strip cards, sports collectibles, souvenirs and other solid collectibles. The foregoing liquid includes inks, paints, dyes, dyestuffs, color wash, pigments, seals, glues, cosmetics and others. After labeling with nucleic acid, the objects have anti-counterfeiting function.
  • For marking solid substances or articles, the water-insoluble medium containing known nucleic acid taggants is spread on the target solid substances or articles. After drying, the nucleic acid taggants protected by the water-insoluble medium adhere on the surface of the object.
  • For marking liquid, the target liquid is mixed with the water-insoluble media containing known nucleic acid taggants. As a result, the target liquid is labeled with nucleic acid.
  • Also, products with nucleic acid labeled are manufactured by means of materials of water-insoluble medium containing nucleic acid taggants.
  • Both solid and liquid are labeled in the present invention. For authentication, a small portion of the labeled substances is dissolved with an organic solvent and then mixed with a buffer of high nucleic acid solubility. The nucleic acid taggants dissolved in the buffer are separated and collected from the solvent by centrifugation. Finally, the collected nucleic acid taggants are amplified by Polymerase Chain Reaction (PCR) and examined by gel electrophoresis.
  • Since the sequence of the nucleic acid taggant is specific, the original nucleic acid will be amplified only with the primers of specific sequences. In addition, the concentration of the nucleic acid in the medium is so low that the sequence of the nucleic acid taggant is hard to be decoded. The purpose of anti-counterfeiting is then achieved.
  • For more detailed information regarding advantages and features of the present invention, examples of preferred embodiments will be described below with reference to the drawings. Both the foregoing general description and the following detailed description are exemplary and explanatory and are intended to provide further explanation of the invention as claimed.
  • BRIEF DESCRIPTION OF THE DRAWINGS
  • The related drawing in connection with the detailed description of the present invention to be made later is described briefly as follows, in which:
  • FIG. 1. shows 800 base pair (bp) DNA taggants which are recovered from a small portion of a plastic film, amplified by PCR and stained with ethidium bromide (EtBr) after gel electrophoresis.
  • FIG. 2. shows 600 bp human WBC DNA taggants recovered from a small portion of a plastic film, amplified by PCR and stained with ethidium bromide (EtBr) after gel electrophoresis.
  • FIG. 3. shows 500 bp E. coli plasmid DNA taggants recovered from paraffin oil, amplified by PCR and stained with ethidium bromide (EtBr) after gel electrophoresis.
  • DETAILED DESCRIPTION OF THE PREFERRED EMBODIMENT
  • Several preferred embodiments of the present invention are described in detail below with reference to the drawings annexed. It should be understood that these examples are intended to be illustrative only and that the present invention is not limited to the conditions or materials recited therein.
  • EXAMPLE 1
  • Mixing DNA With Polystyrene (PS)
  • 5 μg of prepared DNA is dissolved in 100 μl of distilled water to form a DNA solution. 5 g of PS is dissolved in 50 ml chloroform to a concentration of 10% (w/v). 10 μl of 95% ethanol and acetone, as intermediate solution, are added respectively to the DNA solution. Then, DNA solution containing the intermediate solution is mixed homogeneously with the PS/chloroform solution through vigorous vortex. Through such intermediate process, water-soluble DNA solution and water-insoluble medium of PS/chloroform solution are mixed completely to form a homogenous medium containing desired DNA.
  • EXAMPLE 2
  • Marking Plastic Films With Synthesized DNA Taggants For Anti-Counterfeiting and Authentication
  • Synthesized DNA of 800 bp is dissolved in 95% ethanol and acetone in equal amount and mixed with polycarbonate/chloroform solution as mentioned above. A plastic film is spread with the homogenous medium containing desired DNA and air-dried. After drying, the plastic film is placed in the dark, or at 4° C. Alternatively, the plastic film is exposed to sunlight for one day before recovery. For recovery, a small piece of the plastic film is dissolved with chloroform. TE buffer is added and mixed well with the dissolved plastic film in chloroform and then centrifuged. The supernatants are collected and served as the templates for PCR. PCR products are then analyzed by electrophoresis and stained with EtBr. As indicated in FIG. 1, samples labeled with DNA taggants show a clear band of 800 bp on the gel. From left to right, L1 is the standard 100 bp DNA ladder. L2 is PCR products amplified from the sample retrieved from the dark. L3, L4, and L5 are PCR products amplified from samples exposed under sunlight. L6, L7, and L8 are PCR products amplified from samples of 4° C. treatment. Results show that DNA taggants of 800 bp can be recovered from the plastic films with three different treatments and verified through electrophoresis after amplification of PCR.
  • EXAMPLE 3
  • Marking Plastic Films With Human White Blood Cell (WBC) DNA Taggants For Anti-Counterfeiting and Authentication
  • The extracted Human WBC DNA is dissolved in 95% ethanol and equal amount of acetone and then mixed with polycarbonate/chloroform solution as mentioned above. The plastic film is spread with the homogenous medium containing desired DNA and air-dried. After drying, the plastic film is placed in the dark, or at 4° C. Alternatively, the plastic film is exposed to sunlight for one day before recovery. For recovery, a small piece of the plastic film is dissolved with chloroform. TE buffer is added and mixed well with the dissolved plastic film in chloroform and then centrifuged. The supernatants are collected and served as the templates for PCR. PCR products are then analyzed by electrophoresis and stained with EtBr. As indicated in FIG. 2, samples labeled with Human WBC DNA taggants show a clear band of 600 bp on the gel. From left to right, L1 is the standard 100 bp DNA ladder. L2 and L3 are PCR products amplified from the template of 1 μl of the supernatant. L4 and L5 are PCR products amplified from the template of 2 μl of the supernatant. L6 is the PCR product amplified without DNA template (the negative control). L7 is the PCR product amplified with human WBC DNA (positive control). Results show that human WBC DNA can be recovered from the plastic films with three different treatments and verified through electrophoresis after amplification of PCR.
  • EXAMPLE 4 Marking Paraffin Oil With E. coli Plasmid DNA Taggants For Anti-Counterfeiting and Authentication
  • Four treatments are described as follows. In L1: 1 μl of E. coli plasmid DNA (100 pg/μl) is dissolved in 5 μl water and then mixed with paraffin oil directly. L1 is a comparison treatment. In L2: 1 μl of E. coli plasmid DNA (100 pg/μl) is added in 50 μl polycarbonate first and then with paraffin oil. L3 is the negative control, which contains only paraffin oil and polycarbonate/chloroform solution. LA is the positive control, which contains only E. coli plasmid DNA. L1˜L4 are centrifuged at 6000 g for 1 minute. 10 μl of the supernant is used for DNA extraction by phenol-chloroform. The extracted DNA is dissolved in 30 μl water. 1 μl of the extracted DNA solution serving as template is used for PCR reaction. The PCR products are analyzed by electrophoresis. As shown in FIG. 3, it is clear that E. coli plasmid DNA of L1 is not recovered before the addition of polycarbonate/chloroform solution. In L2: DNA is mixed with paraffin oil and recovered through the addition of polycarbonate/chloroform solution. M is the standard 100 bp DNA ladder.

Claims (18)

1. A method of marking a solid article or substance, comprising the following steps:
dissolving a water-insoluble medium in a first solvent to form a first mixture;
mixing a nucleic acid solution with an intermediate solution to form a second mixture;
mixing the second mixture with the first mixture to form a homogenous third mixture;
marking the article or substance with the third mixture containing said nucleic acid; and
drying the labeled article or substance;
wherein the medium is an inert medium and is not deteriorative to the article or substance, and
wherein the intermediate solution increases the miscibility between the first mixture and the second mixture.
2. The method as claimed in claim 1, wherein the water-insoluble medium is a polymeric substance.
3. The method as claimed in claim 2, wherein the polymeric substance is selected from a group consisting of polycarbonate (PC), polymethyl methacrylate (PMMA), polystyrene (PS), and polypropylene (PP).
4. The method as claimed in claim 1, wherein the first solvent is a non-polar solvent.
5. The method as claimed in claim 4, wherein the non-polar solvent is selected from a group consisting of chloroform, dichloromethane, xylene and toluene.
6. The method as claimed in claim 1, wherein the intermediate solution is a semi-polar solvent.
7. The method as claimed in claim 6, wherein the intermediate solution is selected from a group consisting of methanol, ethanol, acetone, glycerol and their mixture.
8. The method as claimed in claim 1, wherein the nucleic acid is selected from a group consisting of a natural and a synthetic nucleic acid.
9. The method as claimed in claim 8, wherein the synthetic nucleic acid is a synthetic vector.
10. The method as claimed in claim 8, wherein the synthetic nucleic acid is a nucleic acid fragment.
11. A method of marking a water insoluble liquid, comprising the following steps:
dissolving a nucleic acid in a aqueous solution to form a first mixture;
mixing the first mixture with an intermediate solution to form a second mixture;
mixing the second mixture with a water insoluble solvent to form a homogenous third mixture; and
mixing and marking the liquid with the third mixture;
wherein the intermediate solution increases the miscibility between the second mixture and the water insoluble solvent.
12. The method as claimed in claim 11, wherein the water insoluble solvent is a non-polar solvent.
13. The method as claimed in claim 12, wherein the non-polar solvent is selected from a group consisting of chloroform, dichloromethane, xylene and toluene.
14. The method as claimed in claim 11, wherein the intermediate solution is a semi-polar solvent.
15. The method as claimed in claim 14, wherein the intermediate solution is selected from a group consisting of methanol, ethanol, acetone, glycerol and their mixture.
16. The method as claimed in claim 11, wherein the nucleic acid is selected from a group consisting of a natural and a synthetic nucleic acid.
17. The method as claimed in claim 16, wherein the synthetic nucleic acid comprises a synthetic vector.
18. The method as claimed in claim 16, wherein the synthetic nucleic acid comprises a nucleic acid fragment.
US10/748,412 2001-04-09 2003-12-29 Method of marking solid or liquid substances with nucleic acid for anti-counterfeiting and authentication Expired - Lifetime US7115301B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
US10/748,412 US7115301B2 (en) 2001-04-09 2003-12-29 Method of marking solid or liquid substances with nucleic acid for anti-counterfeiting and authentication

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US09/832,048 US20020187263A1 (en) 2001-04-09 2001-04-09 Method of utilizing ribonucleic acid as markers for product anti-counterfeit labeling and verification
US10/748,412 US7115301B2 (en) 2001-04-09 2003-12-29 Method of marking solid or liquid substances with nucleic acid for anti-counterfeiting and authentication

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
US09/832,048 Continuation-In-Part US20020187263A1 (en) 2001-04-09 2001-04-09 Method of utilizing ribonucleic acid as markers for product anti-counterfeit labeling and verification

Publications (2)

Publication Number Publication Date
US20050008762A1 true US20050008762A1 (en) 2005-01-13
US7115301B2 US7115301B2 (en) 2006-10-03

Family

ID=46301769

Family Applications (1)

Application Number Title Priority Date Filing Date
US10/748,412 Expired - Lifetime US7115301B2 (en) 2001-04-09 2003-12-29 Method of marking solid or liquid substances with nucleic acid for anti-counterfeiting and authentication

Country Status (1)

Country Link
US (1) US7115301B2 (en)

Cited By (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2434570A (en) * 2006-01-31 2007-08-01 Alexander Peter Mackay Applying DNA as an item label
DE102008064168A1 (en) 2008-12-22 2010-06-24 Leibniz-Institut Für Neue Materialien Gemeinnützige Gmbh Method and composition for producing gradient element optical elements
US20140104331A1 (en) * 2011-06-22 2014-04-17 Smartwater Limited Method for applying a marker to an electrical cable during manufacture
WO2014190109A3 (en) * 2013-05-22 2015-07-16 Sunpower Technologies Llc Method for distinguishing biological material products
JP2016500518A (en) * 2012-10-10 2016-01-14 アプライド ディーエヌエー サイエンシズ インコーポレイテッド Use of perturbants to facilitate taggant incorporation and recovery in polymeric coatings.
JP2016521129A (en) * 2013-03-07 2016-07-21 アプライド ディーエヌエー サイエンシズ インコーポレイテッド Alkaline activation to immobilize DNA taggants
US9428792B2 (en) 2013-03-14 2016-08-30 Certirx Corporation Nucleic acid-based authentication and identification codes
US9904734B2 (en) 2013-10-07 2018-02-27 Apdn (B.V.I.) Inc. Multimode image and spectral reader
US9963740B2 (en) 2013-03-07 2018-05-08 APDN (B.V.I.), Inc. Method and device for marking articles
WO2018115913A1 (en) * 2016-12-23 2018-06-28 Avicor Kutató, Fejlesztö Kft. Nucleic acid based coding process
US10047282B2 (en) 2014-03-18 2018-08-14 Apdn (B.V.I.) Inc. Encrypted optical markers for security applications
US10519605B2 (en) 2016-04-11 2019-12-31 APDN (B.V.I.), Inc. Method of marking cellulosic products
US10705073B2 (en) 2014-06-18 2020-07-07 Ruprecht Keller Method for identifying of a biological sample of a mammal, composition for use in this method and kit for performance of this method
US10741034B2 (en) 2006-05-19 2020-08-11 Apdn (B.V.I.) Inc. Security system and method of marking an inventory item and/or person in the vicinity
US10745825B2 (en) 2014-03-18 2020-08-18 Apdn (B.V.I.) Inc. Encrypted optical markers for security applications
US10920274B2 (en) 2017-02-21 2021-02-16 Apdn (B.V.I.) Inc. Nucleic acid coated submicron particles for authentication
US10995371B2 (en) 2016-10-13 2021-05-04 Apdn (B.V.I.) Inc. Composition and method of DNA marking elastomeric material
US11894119B2 (en) 2019-07-04 2024-02-06 Ruma Gmbh Location-independent ingestion control

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20090286250A1 (en) * 2006-05-19 2009-11-19 James Arthur Hayward Incorporating soluble security markers into cyanoacrylate solutions
US8372648B2 (en) 2003-04-16 2013-02-12 APDN (B.V.I.), Inc. Optical reporter compositions
US20050112610A1 (en) * 2003-04-16 2005-05-26 Applied Dna Sciences, Inc. System and method for marking textiles with nucleic acids
US20100285985A1 (en) * 2003-04-15 2010-11-11 Applied Dna Sciences, Inc. Methods and Systems for the Generation of Plurality of Security Markers and the Detection Therof
US8124333B2 (en) * 2003-04-16 2012-02-28 APDN, Inc. Methods for covalent linking of optical reporters
US8426216B2 (en) * 2003-04-16 2013-04-23 APDN (B.V.I.), Inc. Methods for authenticating articles with optical reporters
US8415165B2 (en) * 2003-04-16 2013-04-09 APDN (B.V.I.), Inc. System and method for authenticating sports identification goods
US8420400B2 (en) * 2003-04-16 2013-04-16 APDN (B.V.I.), Inc. System and method for authenticating tablets
US8415164B2 (en) 2003-04-16 2013-04-09 Apdn (B.V.I.) Inc. System and method for secure document printing and detection
DE102005012567B4 (en) * 2005-03-04 2008-09-04 Identif Gmbh Marking solution, its use and process for its preparation
FR2930063B1 (en) * 2008-04-14 2013-02-15 Bioquanta METHOD FOR MARKING A PRODUCT, METHOD FOR IDENTIFYING THE MARKING AND PRODUCT
US8669079B2 (en) 2008-11-12 2014-03-11 Cara Therapeutics, Inc. Methods for genetic analysis of textiles made of Gossypium barbadense and Gossypium hirsutum cotton
US8940485B2 (en) 2008-11-12 2015-01-27 Apdn (B.V.I.) Inc. Methods for genotyping mature cotton fibers and textiles
US8053744B2 (en) * 2009-04-13 2011-11-08 Src, Inc. Location analysis using nucleic acid-labeled tags
US8703493B2 (en) 2010-06-15 2014-04-22 Src, Inc. Location analysis using fire retardant-protected nucleic acid-labeled tags
US8716027B2 (en) 2010-08-03 2014-05-06 Src, Inc. Nucleic acid-labeled tags associated with odorant
US20150273063A1 (en) * 2012-10-10 2015-10-01 Anthony KUHLMANN Markers for pharmaceuticals
US9266370B2 (en) 2012-10-10 2016-02-23 Apdn (B.V.I) Inc. DNA marking of previously undistinguished items for traceability
US10760182B2 (en) 2014-12-16 2020-09-01 Apdn (B.V.I.) Inc. Method and device for marking fibrous materials
PT109359A (en) 2016-05-03 2017-11-03 Univ Aveiro PORTABLE DEVICE, METHOD FOR READING AUTHENTICATION LABELS AND ITS USES.
EP3593274A1 (en) 2017-03-10 2020-01-15 Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. Methods and system for labeling and detecting a clone-resistant physical unit

Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5139812A (en) * 1989-07-07 1992-08-18 Bioprobe Systems Method and apparatus for high security crypto-marking for protecting valuable objects
US5498283A (en) * 1994-08-23 1996-03-12 Scitex Digital Printing, Inc. Waterfast security inks
US5599578A (en) * 1986-04-30 1997-02-04 Butland; Charles L. Technique for labeling an object for its identification and/or verification
US5643728A (en) * 1992-08-26 1997-07-01 Slater; James Howard Method of marking a liquid
US6261809B1 (en) * 1997-09-05 2001-07-17 November Aktiengesellschaft Gesellschaft Fur Molekulare Medizin Method for marking solid, liquid or gaseous substances
US6312911B1 (en) * 1999-05-06 2001-11-06 Frank Carter Bancroft DNA-based steganography

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69028402T2 (en) 1989-05-22 1997-04-17 Hoffmann La Roche METHOD FOR MARKING AND DETECTING SUBSTANCES WITH NUCLEIC ACIDS
GB9309184D0 (en) * 1993-05-05 1993-06-16 Ici Plc New indelible ink formulation
GB2390055B (en) * 2002-03-22 2005-09-07 Cypher Science Internat Ltd A marking apparatus

Patent Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5599578A (en) * 1986-04-30 1997-02-04 Butland; Charles L. Technique for labeling an object for its identification and/or verification
US5139812A (en) * 1989-07-07 1992-08-18 Bioprobe Systems Method and apparatus for high security crypto-marking for protecting valuable objects
US5643728A (en) * 1992-08-26 1997-07-01 Slater; James Howard Method of marking a liquid
US5498283A (en) * 1994-08-23 1996-03-12 Scitex Digital Printing, Inc. Waterfast security inks
US6261809B1 (en) * 1997-09-05 2001-07-17 November Aktiengesellschaft Gesellschaft Fur Molekulare Medizin Method for marking solid, liquid or gaseous substances
US6312911B1 (en) * 1999-05-06 2001-11-06 Frank Carter Bancroft DNA-based steganography

Cited By (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2434570A (en) * 2006-01-31 2007-08-01 Alexander Peter Mackay Applying DNA as an item label
US10741034B2 (en) 2006-05-19 2020-08-11 Apdn (B.V.I.) Inc. Security system and method of marking an inventory item and/or person in the vicinity
DE102008064168A1 (en) 2008-12-22 2010-06-24 Leibniz-Institut Für Neue Materialien Gemeinnützige Gmbh Method and composition for producing gradient element optical elements
WO2010072390A1 (en) 2008-12-22 2010-07-01 Leibniz-Institut Für Neue Materialien Gemeinnützig Gmbh Method and composition for producing optical elements having a gradient structure
US8497051B2 (en) 2008-12-22 2013-07-30 Leibniz-Institut Fuer Neue Materialien Gemeinnuetzige Gmbh Method and composition for producing optical elements having a gradient structure
US20140104331A1 (en) * 2011-06-22 2014-04-17 Smartwater Limited Method for applying a marker to an electrical cable during manufacture
JP2016500518A (en) * 2012-10-10 2016-01-14 アプライド ディーエヌエー サイエンシズ インコーポレイテッド Use of perturbants to facilitate taggant incorporation and recovery in polymeric coatings.
EP2906721A4 (en) * 2012-10-10 2016-04-20 Applied Dna Sciences Inc Use of perturbants to facilitate incorporation and recovery of taggants from polymerized coatings
US10059981B2 (en) 2012-10-10 2018-08-28 Apdn (B.V.I.) Inc. Use of perturbants to facilitate incorporation and recovery of taggants from polymerized coatings
JP2016521129A (en) * 2013-03-07 2016-07-21 アプライド ディーエヌエー サイエンシズ インコーポレイテッド Alkaline activation to immobilize DNA taggants
US9963740B2 (en) 2013-03-07 2018-05-08 APDN (B.V.I.), Inc. Method and device for marking articles
US9428792B2 (en) 2013-03-14 2016-08-30 Certirx Corporation Nucleic acid-based authentication and identification codes
WO2014190109A3 (en) * 2013-05-22 2015-07-16 Sunpower Technologies Llc Method for distinguishing biological material products
US9904734B2 (en) 2013-10-07 2018-02-27 Apdn (B.V.I.) Inc. Multimode image and spectral reader
US10282480B2 (en) 2013-10-07 2019-05-07 Apdn (B.V.I) Multimode image and spectral reader
US10047282B2 (en) 2014-03-18 2018-08-14 Apdn (B.V.I.) Inc. Encrypted optical markers for security applications
US10745825B2 (en) 2014-03-18 2020-08-18 Apdn (B.V.I.) Inc. Encrypted optical markers for security applications
US10705073B2 (en) 2014-06-18 2020-07-07 Ruprecht Keller Method for identifying of a biological sample of a mammal, composition for use in this method and kit for performance of this method
US10519605B2 (en) 2016-04-11 2019-12-31 APDN (B.V.I.), Inc. Method of marking cellulosic products
US10995371B2 (en) 2016-10-13 2021-05-04 Apdn (B.V.I.) Inc. Composition and method of DNA marking elastomeric material
WO2018115913A1 (en) * 2016-12-23 2018-06-28 Avicor Kutató, Fejlesztö Kft. Nucleic acid based coding process
US10920274B2 (en) 2017-02-21 2021-02-16 Apdn (B.V.I.) Inc. Nucleic acid coated submicron particles for authentication
US11894119B2 (en) 2019-07-04 2024-02-06 Ruma Gmbh Location-independent ingestion control

Also Published As

Publication number Publication date
US7115301B2 (en) 2006-10-03

Similar Documents

Publication Publication Date Title
US7115301B2 (en) Method of marking solid or liquid substances with nucleic acid for anti-counterfeiting and authentication
JP3628614B2 (en) Probe / mobility modifier complex for multiplex nucleic acid detection
CN109715825B (en) Method for detecting target nucleic acid in sample
CA2587419C (en) Compositions for marking objects with dna and methods for marking and linking an object to its owner
KR102415404B1 (en) Certification of articles using nucleic acid taggant
EP2906721B1 (en) Use of perturbants to facilitate incorporation and recovery of nucleic acid taggants from polymerized coatings
EP3033435B1 (en) Method for fragmenting nucleic acid by means of transposase
Nathans et al. Specific origin in SV40 DNA replication
Suenaga et al. Evaluation of three methods for effective extraction of DNA from human hair
US20150329856A1 (en) Methods and systems for the generation of a plurality of security markers and the detection therof
US20040058374A1 (en) Method for mixing nucleic acid with a water insoluble medium and appalication thereof
US20160102215A1 (en) Incorporating soluble security markers into cyanoacrylate solutions
CN108753766A (en) Polynucleotides bar code generating at
CN106191045B (en) Index and primer for multiple nucleic acid sequencing
Siles et al. Genetic fingerprinting of grape plant (Vitis vinifera) using random amplified polymorphic DNA (RAPD) analysis and dynamic size-sieving capillary electrophoresis
GB2376686A (en) Storage of encoded information within biological macromolecules
CN109689883A (en) Method for connecting cell constituent and matrix
Zucoloto et al. Molecular markers applied to conservation genetics of american crocodilians
CN109207571A (en) A method of detection endonuclease restriction enzyme site
WO2023116575A1 (en) Adapter for characterizing target polynucleotide, method, and use thereof
Ibrahim Al-Sammarraie et al. Effects of Hair dyes on Sequence Analysis of Hair Mitochondrial DNA Hypervariable Region 1.
TW570982B (en) Nucleic acid as marker for product anti-counterfeiting and identification
Outwater et al. DNA as a security marker
McCue et al. 02 Principles of Biochemistry and Molecular Biology
EP1479779A1 (en) Biological signature of manufactured products

Legal Events

Date Code Title Description
AS Assignment

Owner name: BIOWELL TECHNOLOGY INC., TAIWAN

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:SHEU, JUE-JEI;CHEN, LIN-LIN;CHEN, EMMA;AND OTHERS;REEL/FRAME:014861/0006

Effective date: 20031118

AS Assignment

Owner name: RIXFLEX HOLDINGS LIMITED, VIRGIN ISLANDS, BRITISH

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:BIOWELL TECHNOLOGY INC.;REEL/FRAME:016664/0936

Effective date: 20050510

STCF Information on status: patent grant

Free format text: PATENTED CASE

AS Assignment

Owner name: APDN (B.V.I) INC., VIRGIN ISLANDS, BRITISH

Free format text: MERGER;ASSIGNORS:RIXFLEX HOLDINGS LIMITED;APDN (B.V.I.) INC.;REEL/FRAME:022804/0358

Effective date: 20050712

FPAY Fee payment

Year of fee payment: 4

AS Assignment

Owner name: ETICO CAPITAL, LLC, NEW YORK

Free format text: PATENT SECURITY AGREEMENT;ASSIGNOR:APDN (B.V.I.) INC.;REEL/FRAME:024710/0239

Effective date: 20100715

AS Assignment

Owner name: APDN (B.V.I.) INC., VIRGIN ISLANDS, BRITISH

Free format text: RELEASE BY SECURED PARTY;ASSIGNOR:ETICO CAPITAL, LLC;REEL/FRAME:028014/0837

Effective date: 20120407

FPAY Fee payment

Year of fee payment: 8

MAFP Maintenance fee payment

Free format text: PAYMENT OF MAINTENANCE FEE, 12TH YR, SMALL ENTITY (ORIGINAL EVENT CODE: M2553)

Year of fee payment: 12

AS Assignment

Owner name: DELAWARE TRUST COMPANY, DELAWARE

Free format text: SECURITY INTEREST;ASSIGNOR:APDN (B.V.I.) INC.;REEL/FRAME:048460/0160

Effective date: 20190226

Owner name: DELAWARE TRUST COMPANY, DELAWARE

Free format text: SECURITY INTEREST;ASSIGNOR:APDN (B.V.I.) INC.;REEL/FRAME:048460/0095

Effective date: 20181019

AS Assignment

Owner name: APDN (B.V.I.) INC., NEW YORK

Free format text: SECURITY INTEREST;ASSIGNOR:DELAWARE TRUST COMPANY;REEL/FRAME:054047/0148

Effective date: 20201009